Assignee
CSPC MEGALITH BIOPHARMACEUTICAL CO LTD
CN·3 granted patents·4 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
7 records- 0171US11285128B2Homogenous antibody drug conjugates via enzymatic methodsCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 29, 2022·0 cites·20 claims
- 0256US2025326838A1Anti-siglec15 antibody and use thereofCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0355US2025345447A1Pharmaceutical composition of recombinant anti-human cldn18.2 monoclonal antibody-mmae conjugateCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0455US2023414774A1Anti-cldn18.2 antibody, drug conjugate, and preparation method therefor and use thereofCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0552US2025345445A1Antibody-drug conjugate and use thereofCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0647US12559534B2Modified IL-2 proteins, peg conjugates, and uses thereofCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 24, 2026·0 cites·15 claims
- 0741US12458818B2Anti-trophoblast cell surface antigen 2 (TROP2) antibodies and antibody drug conjugates comprising sameCSPC MEGALITH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when CSPC MEGALITH BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →